Serum albumin-adjusted glycated albumin is a useful indicator of glycemic control in diabetic patients with end-stage renal disease not on hemodialysis

Serum albumin-adjusted glycated albumin is a useful indicator of glycemic control in diabetic patients with end-stage renal disease not on hemodialysis - Albumin adjusted GA for DM with ESRD

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000015174

Enrollment

Registered

2014-09-16

Start date

2014-05-13

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with diabetic nephropathy CKD4-5

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Diabetic nephropathy CKD stage 4-5 not on HD

Exclusion criteria

Exclusion criteria: cancer

Design outcomes

Primary

Measure	Time frame
Association between SA-adjusted GA and glycemic control	—

Countries

Japan

Contacts

Public ContactKei Fukami

Department of Medicine, Kurume University School of Medicine Division of Nephrology

fukami@med.kurume-u.ac.jp0942-35-3311

Outcome results